Recent Johns Hopkins Medicine Study Analyzes Mislabeled CBD Products

[ad_1]

A study published by Johns Hopkins Medicine on July 20 found that in an evaluation of numerous CBD products, many contained an inaccurate amount of THC. Entitled “Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores,” the study analyzed 105 topical CBD products—specifically lotions, creams, and patches—collected from “online and brick-and-mortar retail locations” in Baltimore, Maryland between July and August 2020 (but analysis didn’t occur until March through June 2022). For storefronts, this included grocery stores, pharmacies, cosmetic and beauty stores, and health and wellness stores.

The study’s lead author, Assistant Professor of Psychiatry and Behavioral Science at Johns Hopkins University School of Medicine, Tory Spindle, Ph.D., explained the objective behind this analysis. “Misleading labels can result in people using poorly regulated and expensive CBD products instead of FDA approved products that are established as safe and effective for a given health condition,” said Spindle.

The results found that 18% of the products contained 10% less CBD than advertised on the label. Additionally, 58% contained 10% more CBD than advertised, while only 24% contained an accurate amount of CBD.

Thirty-five percent of these products contained THC, although the amount per product did not exceed 0.3% THC, which is the legal limit for hemp. Eleven percent of those products were labeled as “THC free,” while 14% said that they contained less than 0.3% THC, and 51% did not mention THC on the labels at all.

Spindle said that the presence of THC in alleged CBD-only products could potentially put some people at risk. “Recent research has shown that people who use CBD products containing even small amounts of THC could potentially test positive for cannabis using a conventional drug test,” Spindle said.

Some of the medical claims made by these products were also inaccurate, and none of them are approved by the U.S. Food and Drug Administration (FDA). Twenty-eight percent made claims about pain or inflammation, 14% made claims regarding cosmetic or beauty, and 47% specifically noted that they were not approved by the FDA, while the other 53% didn’t mention the FDA at all.

The study’s Senior Author, Ryan Vandrey, Ph.D., who is also professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, explained that this stark difference in results requires more research. “The variability in the chemical content and labeling found in our study highlights the need for better regulatory oversight of CBD products to ensure consumer safety,” Vandrey said.

This study is the latest to discuss the inaccuracy of cannabis products. The University of Kentucky also recently analyzed CBD oil products earlier this month, finding that out of 80 CBD oil products, only 43 contained percentages of CBD that were within 10% of the claimed content. The University of Colorado, Boulder, in partnership with Leafly, also found that cannabis labels were inaccurate.

Johns Hopkins University has continually been involved in support cannabis study efforts over the past few years. In September 2019, Johns Hopkins University launched the Center for Psychedelic and Consciousness Research with the goal of expanding research on psychedelic substances in order to create new treatments for specific psychiatric and behavioral disorders. In October 2020, it partnered with Realm of Caring and Bloom Medicinals to work on cannabis therapy research. In October 2021, the university published a study that showed evidence of cannabis successfully treating anxiety and depression. Earlier this year in February, it asked for volunteers to participate in a paid cannabis and alcohol research initiative (which could net up to $2,660 for study completion for an individual).



[ad_2]

Source link

Senate Dems Ready To Introduce Cannabis Bill, Hearing Scheduled Next Week

[ad_1]

With Congress set to break for its traditional August recess––and with this year’s midterm elections drawing nearer––Democrats in the Senate finally appear ready to introduce a bill that would end the federal prohibition on pot.

The Senate Subcommittee on Criminal Justice and Counterterrorism has scheduled a hearing for next week that is titled, “Decriminalizing Cannabis at the Federal Level: Necessary Steps to Address Past Harms.”

The chair of the subcommittee, Sen. Cory Booker (D-NJ), has taken a leading role in crafting the Senate’s cannabis reform legislation.

The hearing is scheduled for Tuesday.

Bloomberg had reported previously that Senate Democrats intended to introduce the bill this week.

Whenever the legislation drops, it will represent long-awaited action from a Democratic caucus that has moved methodically on cannabis reform––despite repeated pledges from party leaders that it will get done.

At the beginning of April, Democrats in the House of Representatives passed their own pot legalization package: the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, which would deschedule cannabis from the Controlled Substances Act.

Senate Democrats said they would move forward with their own cannabis reform bill that has been overseen by Booker, Oregon Sen. Ron Wyden and Senate Majority Leader Chuck Schumer. 

After previously saying that the Senate would release its own version by the end of April, Schumer said that the bill would likely be introduced closer to the Congressional recess in August.

And after recent suggestions that Senate Democrats might be looking to offer up a more modest reform package, it now appears that they will seek to match the House and end the federal prohibition as well.

Politico reported last month that Schumer “doesn’t have the votes to pass a sweeping marijuana decriminalization bill — despite repeatedly touting his support for ending federal prohibition,” and that “realization is leading Senate Democrats to look for a compromise on weed.”

But Bloomberg reported last week that Democrats will indeed introduce the bill that Booker, Wyden and Schumer have been working on: the Cannabis Administration and Opportunity Act, which will also remove pot from the Controlled Substances Act, although it would also give states discretion to establish their own cannabis laws.

Bloomberg noted that “the legislation faces long odds in the evenly divided chamber,” with 60 votes necessary for passage.

The bill faces significant opposition from Republicans in the chamber, and even some Democratic members.

President Joe Biden has long said that he is in favor of decriminalization of cannabis, but not outright legalization––though he has struggled to explain the distinction.

Earlier this week, Biden reiterated his belief that no one “should be in prison for the use of marijuana,” and said that he is working with Congress on a bill to fulfill his promise to release inmates serving time for pot-related offenses.

It is unclear whether he supports either the House’s MORE Act or the Senate’s Cannabis Administration and Opportunity Act.

Despite the slow-motion progress of the bill in the Senate, Schumer has been unequivocal in his support for sweeping cannabis reform.

“We will move forward,” Schumer told Politico last year. “[Biden] said he’s studying the issue, so [I] obviously want to give him a little time to study it. I want to make my arguments to him, as many other advocates will. But at some point we’re going to move forward, period.”

“In 2018, I was the first member of the Democratic leadership to come out in support of ending the federal prohibition. I’m sure you ask, ‘Well what changed?’ Well, my thinking evolved. When a few of the early states—Oregon and Colorado—wanted to legalize, all the opponents talked about the parade of horribles: Crime would go up. Drug use would go up. Everything bad would happen,” he added. “The legalization of states worked out remarkably well. They were a great success. The parade of horribles never came about, and people got more freedom. And people in those states seem very happy.”

[ad_2]

Source link

Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot

[ad_1]

Activists intent on legalizing recreational pot sales in Colorado Springs, Colorado cleared a significant hurdle this week with the announcement that two related adult-use cannabis sales voter initiatives have qualified for the November ballot.

The first ballot measure advanced by the group Your Choice Colorado Springs would legalize recreational weed sales in Colorado Springs, while the second would impose a 5% tax on purchases of adult-use cannabis. If passed by the voters, tax revenue from recreational sales would fund public safety improvements, expand mental health services, and support PTSD programs for veterans.

“Voters in the city stepped up and demanded their voice be heard with respect to ending the prohibition of recreational cannabis sales in Colorado Springs,” Your Choice campaign manager Anthony Carlson said on Monday after announcing the measures had qualified for the ballot. “Especially in these tough economic times, it is critical to ensure every tax dollar that rightfully belongs to Colorado Springs taxpayers stays in our community working to improve our quality of life.”

Colorado voters legalized sales of recreational cannabis with the passage of Amendment 64 in 2012, and regulated sales began in the state two years later. However, the Colorado Springs local government banned recreational cannabis sales in 2013, although the city is home to more than 100 medical dispensaries.

Your Choice Colorado Springs announced its plan for the ballot measure to legalize recreational cannabis sales in January and began circulating petitions to qualify the measures for the ballot in March. Activists had until June 20 to collect 19,245 signatures from Colorado Springs residents. The group far exceeded the requirement, turning in more than 98,000 signatures last month.

Pot Taxes Go to Other Cities

Your Choice Colorado Springs maintains that city residents who purchase adult-use cannabis legally must travel to other communities, which reap the tax benefits of recreational cannabis sales. If the initiatives succeed in this November’s election, a portion of the tax proceeds will help fund mental health services and support PTSD programs for military veterans. Colorado Springs has one of the highest veteran populations in the country, with 17% of adult residents identifying as veterans compared to the national average of 7.1%, according to a recent report from The Center Square.

“Our region led the state in suicides last year,” Carlson said, noting that 30% of those who took their own lives were veterans. “This initiative will provide significant funding to ensure we finally have the resources to take control of this crisis.”

Under the legalization initiative, no additional cannabis retail stores would be permitted in the city, but existing medical cannabis retailers would be able to add recreational cannabis on the same premise as their medical location. Karlie Van Arnam, a small business owner and lead elector sponsoring the initiatives, said the campaign “is about practicality.”

“It makes zero sense to continue the prohibition of a product that is 100% legal to possess and consume in our city,” said Arnam. “This campaign isn’t just about revenue. It’s about personal freedom and choice for our residents. It’s about supporting our small businesses and the thousands of people they employ. It’s about expanding mental health access for citizens and ensuring our veterans have access to world-class PTSD programs right here in Colorado Springs. It’s about time this decision is taken out of the hands of a few politicians and given to the people.”

Colorado Springs Mayor Opposes Legalization

Colorado Springs Mayor John Suthers, who has opposed approving recreational cannabis sales in the city for years, issued a statement warning voters about potentially negative aspects of legalizing.

“I remain vehemently opposed to legalizing recreational marijuana in Colorado Springs. There are no regulations in Colorado limiting THC levels which continue to rise and adversely impact young marijuana users,” said Suthers. “In cities with recreational marijuana, it’s not paying for the full cost of the damage it’s doing. Denver, in particular, offers a cautionary tale. In three years, it has dropped from No. 2 to No. 55 in the U.S. News & World Report rankings for best city to live. The pervasive influence of marijuana is a significant factor.”

Carlson said that despite the opposition from city leaders, voters are likely to approve the ballot measure in this November’s general election.

“Colorado Springs residents overwhelmingly voted to approve Amendment 64 in 2012. Our City Council and Mayor have repeatedly defied the will of Colorado Springs voters by keeping recreational cannabis—and its tax revenues—out of Colorado Springs for the past decade, at a loss of $150 million,” Carlson said in an email to High Times. “Now our citizens have spoken again, submitting a record 98,000 signatures—more than 2.5 times more than required—to get these measures on the ballot. The will of Colorado Springs citizens is crystal clear: They want to keep tax revenues from recreational cannabis in Colorado Springs to support efforts including mental health and veteran services.”

[ad_2]

Source link

Texas Ag Commissioner Voices Support for Medical Pot Access

[ad_1]

Texas Agriculture Commissioner Sid Miller published an editorial on Friday calling for improved access to medical marijuana in the state, writing that state leaders should “lead or just get out of the way if we cannot formulate effective cannabis policy for Texas.”

In the letter, which Miller posted to the Texas Department of Agriculture’s official website, the commissioner noted that he advocated for the legalization of hemp in the state and is now responsible for regulating hundreds of hemp businesses. He wrote that he also supported the development of products for medical use including hemp oil, which are improving the lives of Texans everyday when other medicines have failed. Miller added that he would improve access to medical cannabis in the next year. In 2015, the state legalized the use of low-THC cannabis products as a treatment for epilepsy, adding additional qualifying medical conditions in 2019 and 2021.

“It is my goal next year to expand access to the compassionate use of cannabis products in Texas so that every Texan with a medical need has access to these medicines,” Miller wrote.

Cannabis Enforcement Mire in Bias

In his editorial, Miller noted that the history of cannabis prohibition and enforcement in the United States has been riddled with bias and values not consistent with professed American ideals. He also noted that cannabis policy decisions have often been made based on misinformation and emotion rather than reality and that the government should only make things illegal “for a powerful reason or set of facts.”

“As I look back, I believe that cannabis prohibition came from a place of fear, not from medical science or the analysis of social harm. Sadly, the roots of this came from a history of racism, classism, and a large central government with an authoritarian desire to control others. It is as anti-American in its origins as could be imaginable,” Miller wrote. “Today, in the 21st century, this must end. We must start with a new chapter and a new attitude about the use of cannabis – especially when it comes to its potential medicinal benefits.”

Miller, a Republican, noted in his message that 39 states “including politically conservative states such as Oklahoma, Utah and Florida” have passed measures to legalize the medicinal use of cannabis. More than a dozen others “including conservative western states like Arizona, Montana and Alaska, have legalized commercial cannabis sales” for all adults aged 21 and older.

“While I am not sure that Texas is ready to go that far, I have seen firsthand the value of cannabis as medicine to so many Texans,” Miller wrote.

Mixed Messages from Texas Republicans

The Republican leadership in Texas has not expressed a consistent stance on cannabis policy. While campaigning for re-election in January, Governor Greg Abbot said that Texas prisons should be reserved “for dangerous criminals who may harm others.”

“Small possession of marijuana is not the type of violation that we want to stockpile jails with,” said Abbot.

But Lieutenant Governor Dan Patrick is one of the state’s most vocal cannabis opponents.

“The Lt. Governor has made it pretty explicitly clear that he is not on board for lessening the state’s drug laws around marijuana,” Joshua Blank, research director for the University of Texas Austin’s Texas Politics Project, said earlier this year. “But I think like any other public figure, if pressure continues to mount, especially within his own party, there’s no reason he can’t change his mind.”

Noting that four out of five Texans support the compassionate use of cannabis, Miller called on Abbot and the state’s lawmakers to increase access to medicinal cannabis during the next legislative session.

“It is time for all of us, including the Governor, members of the Texas Legislature and others to come together and set aside our political differences to have an honest conversation about cannabis: where we have been, where we are going and what role government should properly play,” Miller concluded. “We owe it to our fellow Texans, especially those who are suffering, to lead or just get out of the way if we cannot formulate effective cannabis policy for Texas.”

[ad_2]

Source link

California City to Charge Separate Violations Per Illegal Plant

[ad_1]

Brentwood, California officials are fed up with the uptick in home cultivation violations and did something about it.

On July 12, the Brentwood City Council intensified the rules on the home cultivation of cannabis—taking the rules beyond the legal six-plant limit inside a personal residence. Administrative citations may be issued—per plant—for any plants that are grown beyond the legal limit.

The measure was approved by the Brentwood City Council by a 4-0 vote, with Vice Mayor Johnny Rodriguez absent.

Residents should be careful about considering how many plants to grow at home. A $100 citation will be issued for the first violation, $200 for the second violation, and $500 for the third and subsequent violation. What it means is that now each plant will be considered a separate violation.

According to Code Enforcement Supervisor Roberta Portillo-Bienemann, the city has seen an uptick in cannabis cultivation violations. The new rules would give code enforcement agents additional tools to fight illegal home cultivation, putting a bit more pressure on residents who are considering defying the rules.

Typical illegal grow operations have up to 10 violations, Portillo-Bienemann said, but the new rules would add more violations, depending on the number of plants that are found by code enforcement.

Portillo-Bienemann said it usually gives the offender five to seven days to appeal the citation, however the city could issue fines per plant, per day.

“In order to give an individual their due process, right, and their ability to appeal that citation, if they choose to do so, we issue the administrative fines on a weekly basis,” she told the Santa Cruz Sentinel. “It is hoped these revisions will increase the city’s code enforcement capabilities and deter illegal marijuana cultivation.’’

But next door in Antioch, California, the police say there’s no actual problem taking place—at least not in their city.

Antioch Interim Police Chief Steve Ford said that in his city, they haven’t seen any grow houses in the last year, however at least one illegal warehouse grow operation was discovered months ago and punished by code enforcement.

“As crazy as it sounds, I’d like to think that that [the availability of dispensaries] has helped to mitigate the need for people to want to try and erect a weed house or weed grow because they don’t have to do that,” Ford told the Santa Cruz Sentinel.

Brentwood has regulated home cultivation since 2017, when it incorporated California law into its municipal code to reflect Proposition 64. City leaders are mostly worried about large-scale operations, and they say that the crop sizes reach the hundreds or thousands, and they believe it creates health and safety risks.

Brentwood Mayor Joel Bryant said he supported the new home cultivation rules.

“Having seen some of these grow houses in our community, not only is there immediate danger to the neighboring houses of fire and there are health concerns from the mold, but there also have been some violent interactions from criminal activity,” Bryant stated. “Not only from the growers but people that are criminals that found out that that grow house was there.”

Councilwoman Susannah Meyer approved the measure, saying that the enhanced rules don’t impede anyone’s rights to consume cannabis.

Some residents also agreed with the enhanced violations, saying that the issue is about protecting their property values.

Assuming you’re staying within the legal limit in your respective city, and assuming your state allows it, High Times provides guidelines, focusing on the ins and outs of growing cannabis at home.

[ad_2]

Source link

Headset Report Analyzes Turnover Rates for Budtenders in the U.S. and Canada

[ad_1]

The cannabis data collection company Headset released its latest report on July 13, which covers budtender/employee turnover rates in cannabis dispensaries.

Headset calls cannabis budtenders the “heart and soul of the industry,” because they are essentially ambassadors for the plant and the industry. “Because of their extreme importance, budtender hiring, onboarding, and management is one of the most crucial tasks in any cannabis retail operation,” Headset writes in its introduction. “One of the great challenges of managing budtenders, or staff in any business, is employee turnover. Turnover is often unavoidable and always costly, so it’s essential to optimize the employee hiring and managing process wherever possible. In this report, we explore budtender turnover in the US and Canada to get an understanding of what is and isn’t normal when it comes to budtender turnover.”

The report analyzes information collected between June 2021 through May 2022, with a search in Arizona, California, Colorado, Illinois, Massachusetts, Michigan, Nevada, Oregon and Washington state, as well as the Canadian provinces of Alberta, Ontario, British Columbia, and Saskatchewan.

For both the U.S. and Canada, the split between senior employees and new employees is nearly the same. In the U.S., 40.6% are employees that were hired more than 12 months ago, with 59.4% being considered as new hires. In Canada, the split between 12 month employees and new hires is 40.1% and 59.9% respectively.

The percentages begin to differ when reviewing the percentages of employees who stay at cannabis dispensaries versus those who leave before the 12-month mark. In the U.S., 45.4% continued working after one year, but 54.6% left, and in Canada, 43.6% stay on while 56.4% quit.

Further data shows that ~16% of employees in both the U.S. and Canada continued to work at their job, but only ~24% chose to leave. The percentage in relation to new hires choosing to stay or leave is much higher—29.3% and 30.1% in the U.S. 27.3% and 32.5% in Canada.

There are many reasons that could influence budtenders to leave their jobs, and in most cases the data is similar in the markets used for analysis. “Retailers in Illinois, for example, seem to be better than average at retaining more experienced staff members for more than one year with 55% of employees hired more than one year ago,” the report states. “Conversely, retailers in Colorado and Oregon tend to have far lower retention, both with more than a third of budtenders starting and ending their employment in the past 12 months. In Canada, Alberta is a bit of an enigma with retailers tending to have slightly better retention among new employees but having lost a larger amount of more tenured employees than in other Canadian provinces.”

The report also shares that 23% of new hires in the U.S. and 24% in Canada leave before the first 30 days of their employment, which is likely attributed to an “efficient and effect new hire onboarding process.”

However, those who perform well in sales are more likely to continue working. “The better performing the budtender is, the more likely they are to continue working,” Headset concludes. “This could be simply because it feels good to do well at a job and so it’s natural to want to continue. However, budtending is still a tip-driven position in many markets and being a top performer could also mean an employee might be bringing home more total income than his or her coworkers.”

[ad_2]

Source link

Pin It on Pinterest

x  Powerful Protection for WordPress, from Shield Security
This Site Is Protected By
Shield Security